Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ganapathi

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Cancer Communications|February 1, 1991
Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cellsN Kamath, D Grabowski, J Ford, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cellsW M Holleran, M W DeGregorio, R Ganapathi, et al.
Cancer Research|December 16, 1998
Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalphaC E Herzog, K A Holmes, L M Tuschong, et al.
Nanomaterials (Basel, Switzerland)|September 9, 2023
Functionalization of Fluorine on the Surface of SnO<sub>2</sub>-Mg Nanocomposite as an Efficient Photocatalyst for Toxic Dye DegradationG Velmurugan, R Ganapathi Raman, P Sivaprakash, et al.
The Journal of Biological Chemistry|November 25, 1994
Serine 1524 is a major site of phosphorylation on human topoisomerase II alpha protein in vivo and is a substrate for casein kinase II in vitroN J Wells, C M Addison, A M Fry, et al.
Current Cancer Drug Targets|June 29, 2010
DNA topoisomerase II enzymes as molecular targets for cancer chemotherapyK Chikamori, A G Grozav, T Kozuki, et al.
Seminars in Oncology|May 29, 1999
Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostineG T Budd, R Ganapathi, L Wood, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancerG T Budd, R M Bukowski, A Lichtin, et al.
Plant Cell Reports|May 31, 2007
Analysis of the limitations of hepatitis B surface antigen expression in soybean cell suspension culturesT R Ganapathi, G B Sunil Kumar, L Srinivas, et al.
Biotechnology Letters|August 11, 2005
Secretion of hepatitis B surface antigen in transformed tobacco cell suspension culturesG B Sunil Kumar, T R Ganapathi, L Srinivas, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Cancer Communications|February 1, 1991
Trifluoperazine modulation of resistance to the topoisomerase II inhibitor etoposide in doxorubicin resistant L1210 murine leukemia cellsN Kamath, D Grabowski, J Ford, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cellsW M Holleran, M W DeGregorio, R Ganapathi, et al.
Cancer Research|December 16, 1998
Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalphaC E Herzog, K A Holmes, L M Tuschong, et al.
Nanomaterials (Basel, Switzerland)|September 9, 2023
Functionalization of Fluorine on the Surface of SnO<sub>2</sub>-Mg Nanocomposite as an Efficient Photocatalyst for Toxic Dye DegradationG Velmurugan, R Ganapathi Raman, P Sivaprakash, et al.
The Journal of Biological Chemistry|November 25, 1994
Serine 1524 is a major site of phosphorylation on human topoisomerase II alpha protein in vivo and is a substrate for casein kinase II in vitroN J Wells, C M Addison, A M Fry, et al.
Current Cancer Drug Targets|June 29, 2010
DNA topoisomerase II enzymes as molecular targets for cancer chemotherapyK Chikamori, A G Grozav, T Kozuki, et al.
Seminars in Oncology|May 29, 1999
Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostineG T Budd, R Ganapathi, L Wood, et al.
Investigational New Drugs|February 1, 1993
Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancerG T Budd, R M Bukowski, A Lichtin, et al.
Plant Cell Reports|May 31, 2007
Analysis of the limitations of hepatitis B surface antigen expression in soybean cell suspension culturesT R Ganapathi, G B Sunil Kumar, L Srinivas, et al.
Biotechnology Letters|August 11, 2005
Secretion of hepatitis B surface antigen in transformed tobacco cell suspension culturesG B Sunil Kumar, T R Ganapathi, L Srinivas, et al.
Pageof 14